Levothyroxine-induced skin reactions
Pro Research Analysisby 
Searched over 200M research papers
Levothyroxine-Induced Skin Reactions: Types and Clinical Presentations
Levothyroxine, a synthetic thyroid hormone, is widely used to treat hypothyroidism, but skin reactions to this medication are rare. Reported skin reactions include maculopapular rashes, urticarial rashes with angioedema, lichenoid drug eruptions, and erythematous eruptions with severe itching. These reactions can present as itchy, raised rashes on the abdomen, chest, arms, face, neck, and eyelids, sometimes accompanied by swelling and difficulty swallowing. In some cases, the rash appears after weeks or months of therapy and resolves upon discontinuation of the drug 1234567.
Mechanisms and Types of Hypersensitivity Reactions
Levothyroxine-induced skin reactions can be immediate (IgE-mediated) or delayed (non-IgE-mediated, such as type IV hypersensitivity). Delayed reactions are characterized by the appearance of rashes several days to months after starting therapy, and histological findings may show perivasculitis with eosinophil and lymphocyte infiltration. Patch testing and challenge tests can help confirm hypersensitivity to levothyroxine 2356.
Role of Inactive Ingredients in Skin Reactions
Some cases suggest that hypersensitivity reactions may be triggered not by levothyroxine itself, but by inactive ingredients (excipients) in the tablet formulations. Changing the brand or formulation, such as switching to a liquid preparation or a product without certain excipients, has led to resolution of symptoms in both human and animal cases 478.
Management Strategies: Discontinuation, Brand Switching, and Desensitization
The primary management of levothyroxine-induced skin reactions is discontinuation of the offending formulation, which typically leads to resolution of symptoms within weeks. In some cases, switching to a different brand or formulation (including liquid forms) has allowed patients to continue thyroid hormone replacement without recurrence of hypersensitivity 47. For patients who react to multiple formulations and require ongoing thyroid hormone therapy, oral desensitization protocols have been successfully used. These protocols involve gradually increasing doses of levothyroxine under medical supervision, allowing patients to tolerate therapeutic doses without further reactions 25.
Conclusion
Levothyroxine-induced skin reactions are rare but can present as various types of rashes and hypersensitivity responses. These reactions may be due to the active drug or, in some cases, to inactive ingredients in the formulation. Management includes discontinuation, switching formulations, or desensitization protocols. Awareness of these potential reactions and individualized management strategies can help ensure safe and effective treatment for patients with hypothyroidism 12345678.
Sources and full results
Most relevant research papers on this topic